Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Nov 2019 13:47

RNS Number : 6874S
InnovaDerma PLC
07 November 2019
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Directorate Change

 

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, today announces that Haris Chaudhry, the Executive Chairman, has informed the Board of his decision to leave the Company with immediate effect. Haris Chaudhry is departing for personal reasons and to pursue other interests.

 

The Board has agreed that with immediate effect, Haris Chaudhry will resign as Executive Chairman and relinquish his responsibilities but remain available to the Company to ensure the orderly handover and continued smooth running of the Life Sciences business, for which he had responsibility.

 

Joe Bayer, Finance Director and Executive Director of the Company, has been appointed Executive Chairman with immediate effect. Joe Bayer joined the Company as a Non-executive Director and an initial investor in 2014. In 2015 he was appointed Finance Director and Executive Director. Joe has more than three decades of international consumer and healthcare experience in senior executive positions. He will continue to oversee the finance function of the business and the Company will review the role of Finance Director and transition the role to a suitable candidate in due course. The Company currently has two non-executive directors and will look to broaden the board composition to ensure it has the right expertise and balance to maintain the continued success of the business and implement the next stage of growth.

 

As announced in the Company's trading statement yesterday, InnovaDerma continues to trade in line with market expectations. For the first four months of the new financial year, revenues were 38% higher compared with the same period last year, underpinned by strong performances across our topical brands and Prolong, both in retail stores and through our growing DTC channels. The Company will launch a new skin-care related category with Superdrug across all c.800 of its stores in H2 of FY 2020.

 

Joe Bayer, Executive Chairman of InnovaDerma, said:

 

"On behalf of the team at InnovaDerma, I would like to thank Haris for his deep commitment, leadership and contribution to the business over the years. It is his entrepreneurial spirit which founded the business and he took InnovaDerma from a pre-revenue to a multi-brand business. He leaves behind a company in the best shape it has ever been and at the forefront of several product categories. We wish him all the best for the future."

 

Haris Chaudhry, said:

 

"I am very proud of everything the team at InnovaDerma has achieved. Since I started the Company in 2013, the business has gone from strength to strength achieving profitable growth year after year. The business is maturing and I believe that the time is now right for me to pursue more entrepreneurial opportunities. I would like to thank the fantastic team at InnovaDerma and wish them the very best for the future."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

 

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil Ð Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFSMFDWFUSELF
Date   Source Headline
15th Feb 202112:22 pmBUSForm 8.3 - INNOVADERMA PLC
12th Feb 20216:25 pmRNSForm 8.3 - Innovaderma PLC
12th Feb 20214:43 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20214:40 pmRNSForm 8.3 - [InnovaDerma plc]
12th Feb 20212:35 pmRNSForm 8.3 - Creightons
11th Feb 202111:50 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:25 amRNSForm 8.3 - Innovaderma plc
10th Feb 202111:03 amRNSForm 8.3 - Innovaderma PLC
9th Feb 20211:18 pmBUSForm 8.3 - INNOVADERMA PLC
5th Feb 20215:14 pmRNSForm 8.3 - Innovaderma Plc
4th Feb 20215:37 pmRNSForm 8 (OPD) CREIGHTONS
4th Feb 20213:31 pmRNSForm 8 (OPD) InnovaDerma PLC
3rd Feb 202112:27 pmBUSForm 8.3 - Innovaderma Plc
2nd Feb 20214:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:35 pmRNSPrice Monitoring Extension
2nd Feb 20214:12 pmGNWForm 8.3 - [InnovaDerma plc]
2nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 202111:41 amRNSStatement re Possible Offer
2nd Feb 202111:05 amRNSSecond Price Monitoring Extn
2nd Feb 202111:00 amRNSPrice Monitoring Extension
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 202111:22 amRNSHolding(s) in Company
22nd Jan 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20219:19 amRNSProposed Placing and Proposed Open Offer
18th Jan 202111:59 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:35 pmRNSPrice Monitoring Extension
15th Jan 20217:00 amRNSLoan Agreement
11th Jan 20217:08 amRNSTrading Statement
16th Dec 202012:18 pmRNSResults of the AGM and GM and Directorate Change
2nd Dec 20207:00 amRNSDirectorate Change
24th Nov 20207:02 amRNSDirectorate Change
24th Nov 20207:00 amRNSNotice of General Meeting and adjournment of AGM
18th Nov 20207:00 amRNSDirectorate Change
11th Nov 202012:07 pmRNSAdjournment of AGM
29th Oct 20208:45 amRNSHolding(s) in Company
29th Oct 20208:28 amRNSDirector/PDMR Shareholding
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn
27th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:01 pmRNSPrice Monitoring Extension
23rd Oct 20202:05 pmRNSRequisition notice and Progress of CEO appointment
16th Oct 20204:32 pmRNSNotice of AGM
16th Oct 20209:21 amRNSAppointment of Non-executive Director
15th Oct 20204:40 pmRNSSecond Price Monitoring Extn
15th Oct 20204:35 pmRNSPrice Monitoring Extension
15th Oct 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.